nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—MPO—Carboplatin—testicular cancer	0.379	0.539	CbGbCtD
Cysteamine—MPO—Cisplatin—testicular cancer	0.324	0.461	CbGbCtD
Cysteamine—SST—vein—testicular cancer	0.0747	0.757	CbGeAlD
Cysteamine—SST—embryo—testicular cancer	0.0141	0.143	CbGeAlD
Cysteamine—SST—Peptide ligand-binding receptors—INSL3—testicular cancer	0.00628	0.142	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—INSL3—testicular cancer	0.00602	0.136	CbGpPWpGaD
Cysteamine—SST—lymph node—testicular cancer	0.00501	0.0508	CbGeAlD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.00421	0.0953	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.00404	0.0913	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—INSL3—testicular cancer	0.00321	0.0725	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—INSL3—testicular cancer	0.00307	0.0695	CbGpPWpGaD
Cysteamine—MPO—testis—testicular cancer	0.00278	0.0282	CbGeAlD
Cysteamine—MPO—C-MYB transcription factor network—MAD1L1—testicular cancer	0.0022	0.0499	CbGpPWpGaD
Cysteamine—MPO—lymph node—testicular cancer	0.00202	0.0205	CbGeAlD
Cysteamine—SST—GPCR downstream signaling—INSL3—testicular cancer	0.00181	0.041	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—INSL3—testicular cancer	0.00174	0.0393	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—INSL3—testicular cancer	0.00165	0.0372	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—INSL3—testicular cancer	0.00158	0.0357	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—H2AFZ—testicular cancer	0.00154	0.0348	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—KITLG—testicular cancer	0.00141	0.032	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—INSL3—testicular cancer	0.000972	0.022	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—KIT—testicular cancer	0.000965	0.0218	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—INSL3—testicular cancer	0.000932	0.0211	CbGpPWpGaD
Cysteamine—Hepatic function abnormal—Epirubicin—testicular cancer	0.000452	0.00291	CcSEcCtD
Cysteamine—Discomfort—Ifosfamide—testicular cancer	0.000452	0.00291	CcSEcCtD
Cysteamine—Hypersensitivity—Vinblastine—testicular cancer	0.000447	0.00288	CcSEcCtD
Cysteamine—Decreased appetite—Bleomycin—testicular cancer	0.000446	0.00287	CcSEcCtD
Cysteamine—Confusional state—Ifosfamide—testicular cancer	0.000442	0.00285	CcSEcCtD
Cysteamine—Immune system disorder—Etoposide—testicular cancer	0.00044	0.00284	CcSEcCtD
Cysteamine—Anaphylactic shock—Ifosfamide—testicular cancer	0.000438	0.00283	CcSEcCtD
Cysteamine—Eye pain—Epirubicin—testicular cancer	0.000437	0.00282	CcSEcCtD
Cysteamine—Mental disability—Doxorubicin—testicular cancer	0.000437	0.00282	CcSEcCtD
Cysteamine—Asthenia—Vinblastine—testicular cancer	0.000435	0.00281	CcSEcCtD
Cysteamine—Tremor—Cisplatin—testicular cancer	0.000434	0.0028	CcSEcCtD
Cysteamine—Lethargy—Methotrexate—testicular cancer	0.00043	0.00278	CcSEcCtD
Cysteamine—Nervous system disorder—Ifosfamide—testicular cancer	0.00043	0.00277	CcSEcCtD
Cysteamine—Anaemia—Cisplatin—testicular cancer	0.000428	0.00276	CcSEcCtD
Cysteamine—Skin disorder—Ifosfamide—testicular cancer	0.000426	0.00275	CcSEcCtD
Cysteamine—Feeling abnormal—Bleomycin—testicular cancer	0.000422	0.00273	CcSEcCtD
Cysteamine—Vomiting—Chlorambucil—testicular cancer	0.000421	0.00272	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Doxorubicin—testicular cancer	0.00042	0.00271	CcSEcCtD
Cysteamine—Hepatic function abnormal—Doxorubicin—testicular cancer	0.000418	0.0027	CcSEcCtD
Cysteamine—Anorexia—Ifosfamide—testicular cancer	0.000418	0.00269	CcSEcCtD
Cysteamine—Decreased appetite—Dactinomycin—testicular cancer	0.000416	0.00268	CcSEcCtD
Cysteamine—Diarrhoea—Vinblastine—testicular cancer	0.000415	0.00268	CcSEcCtD
Cysteamine—Leukopenia—Cisplatin—testicular cancer	0.000414	0.00267	CcSEcCtD
Cysteamine—Fatigue—Dactinomycin—testicular cancer	0.000412	0.00266	CcSEcCtD
Cysteamine—Urticaria—Bleomycin—testicular cancer	0.000407	0.00263	CcSEcCtD
Cysteamine—Body temperature increased—Bleomycin—testicular cancer	0.000405	0.00261	CcSEcCtD
Cysteamine—Eye pain—Doxorubicin—testicular cancer	0.000404	0.00261	CcSEcCtD
Cysteamine—Lethargy—Epirubicin—testicular cancer	0.000403	0.0026	CcSEcCtD
Cysteamine—Dizziness—Vinblastine—testicular cancer	0.000401	0.00259	CcSEcCtD
Cysteamine—Convulsion—Cisplatin—testicular cancer	0.000401	0.00259	CcSEcCtD
Cysteamine—Mood swings—Methotrexate—testicular cancer	0.000399	0.00258	CcSEcCtD
Cysteamine—Ataxia—Methotrexate—testicular cancer	0.000397	0.00256	CcSEcCtD
Cysteamine—Pain in extremity—Epirubicin—testicular cancer	0.000395	0.00255	CcSEcCtD
Cysteamine—Feeling abnormal—Dactinomycin—testicular cancer	0.000394	0.00254	CcSEcCtD
Cysteamine—Nausea—Chlorambucil—testicular cancer	0.000393	0.00254	CcSEcCtD
Cysteamine—Anaemia—Etoposide—testicular cancer	0.000392	0.00253	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000391	0.00252	CcSEcCtD
Cysteamine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000391	0.00252	CcSEcCtD
Cysteamine—Somnolence—Ifosfamide—testicular cancer	0.000389	0.00251	CcSEcCtD
Cysteamine—Liver function test abnormal—Methotrexate—testicular cancer	0.000389	0.00251	CcSEcCtD
Cysteamine—Discomfort—Cisplatin—testicular cancer	0.000389	0.00251	CcSEcCtD
Cysteamine—Affect lability—Epirubicin—testicular cancer	0.000388	0.00251	CcSEcCtD
Cysteamine—Vomiting—Vinblastine—testicular cancer	0.000386	0.00249	CcSEcCtD
Cysteamine—Decreased appetite—Ifosfamide—testicular cancer	0.000381	0.00246	CcSEcCtD
Cysteamine—Headache—Vinblastine—testicular cancer	0.00038	0.00245	CcSEcCtD
Cysteamine—Leukopenia—Etoposide—testicular cancer	0.00038	0.00245	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000378	0.00244	CcSEcCtD
Cysteamine—Abdominal pain—Dactinomycin—testicular cancer	0.000378	0.00244	CcSEcCtD
Cysteamine—Body temperature increased—Dactinomycin—testicular cancer	0.000378	0.00244	CcSEcCtD
Cysteamine—Fatigue—Ifosfamide—testicular cancer	0.000378	0.00244	CcSEcCtD
Cysteamine—Anaphylactic shock—Cisplatin—testicular cancer	0.000378	0.00244	CcSEcCtD
Cysteamine—Hypersensitivity—Bleomycin—testicular cancer	0.000378	0.00244	CcSEcCtD
Cysteamine—Constipation—Ifosfamide—testicular cancer	0.000375	0.00242	CcSEcCtD
Cysteamine—Mood swings—Epirubicin—testicular cancer	0.000374	0.00241	CcSEcCtD
Cysteamine—Lethargy—Doxorubicin—testicular cancer	0.000373	0.0024	CcSEcCtD
Cysteamine—Ataxia—Epirubicin—testicular cancer	0.000371	0.00239	CcSEcCtD
Cysteamine—Nervous system disorder—Cisplatin—testicular cancer	0.00037	0.00239	CcSEcCtD
Cysteamine—Asthenia—Bleomycin—testicular cancer	0.000368	0.00237	CcSEcCtD
Cysteamine—Convulsion—Etoposide—testicular cancer	0.000367	0.00237	CcSEcCtD
Cysteamine—Dehydration—Epirubicin—testicular cancer	0.000367	0.00237	CcSEcCtD
Cysteamine—Skin disorder—Cisplatin—testicular cancer	0.000367	0.00237	CcSEcCtD
Cysteamine—Hypertension—Etoposide—testicular cancer	0.000366	0.00236	CcSEcCtD
Cysteamine—Pain in extremity—Doxorubicin—testicular cancer	0.000365	0.00236	CcSEcCtD
Cysteamine—Liver function test abnormal—Epirubicin—testicular cancer	0.000364	0.00235	CcSEcCtD
Cysteamine—Feeling abnormal—Ifosfamide—testicular cancer	0.000361	0.00233	CcSEcCtD
Cysteamine—Nausea—Vinblastine—testicular cancer	0.000361	0.00233	CcSEcCtD
Cysteamine—Anorexia—Cisplatin—testicular cancer	0.00036	0.00232	CcSEcCtD
Cysteamine—Affect lability—Doxorubicin—testicular cancer	0.000359	0.00232	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000358	0.00231	CcSEcCtD
Cysteamine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000358	0.00231	CcSEcCtD
Cysteamine—Discomfort—Etoposide—testicular cancer	0.000357	0.0023	CcSEcCtD
Cysteamine—Hypersensitivity—Dactinomycin—testicular cancer	0.000352	0.00227	CcSEcCtD
Cysteamine—Confusional state—Etoposide—testicular cancer	0.000349	0.00225	CcSEcCtD
Cysteamine—Urticaria—Ifosfamide—testicular cancer	0.000348	0.00225	CcSEcCtD
Cysteamine—Abdominal pain—Ifosfamide—testicular cancer	0.000346	0.00223	CcSEcCtD
Cysteamine—Body temperature increased—Ifosfamide—testicular cancer	0.000346	0.00223	CcSEcCtD
Cysteamine—Anaphylactic shock—Etoposide—testicular cancer	0.000346	0.00223	CcSEcCtD
Cysteamine—Mood swings—Doxorubicin—testicular cancer	0.000346	0.00223	CcSEcCtD
Cysteamine—Ataxia—Doxorubicin—testicular cancer	0.000343	0.00221	CcSEcCtD
Cysteamine—Asthenia—Dactinomycin—testicular cancer	0.000343	0.00221	CcSEcCtD
Cysteamine—Dehydration—Doxorubicin—testicular cancer	0.00034	0.00219	CcSEcCtD
Cysteamine—Liver function test abnormal—Doxorubicin—testicular cancer	0.000337	0.00217	CcSEcCtD
Cysteamine—Skin disorder—Etoposide—testicular cancer	0.000336	0.00217	CcSEcCtD
Cysteamine—Anorexia—Etoposide—testicular cancer	0.00033	0.00213	CcSEcCtD
Cysteamine—Decreased appetite—Cisplatin—testicular cancer	0.000328	0.00212	CcSEcCtD
Cysteamine—Diarrhoea—Dactinomycin—testicular cancer	0.000327	0.00211	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000326	0.0021	CcSEcCtD
Cysteamine—Vomiting—Bleomycin—testicular cancer	0.000326	0.0021	CcSEcCtD
Cysteamine—Rash—Bleomycin—testicular cancer	0.000323	0.00209	CcSEcCtD
Cysteamine—Dermatitis—Bleomycin—testicular cancer	0.000323	0.00208	CcSEcCtD
Cysteamine—Hypersensitivity—Ifosfamide—testicular cancer	0.000323	0.00208	CcSEcCtD
Cysteamine—Renal failure—Methotrexate—testicular cancer	0.000319	0.00206	CcSEcCtD
Cysteamine—Asthenia—Ifosfamide—testicular cancer	0.000314	0.00203	CcSEcCtD
Cysteamine—Feeling abnormal—Cisplatin—testicular cancer	0.000311	0.00201	CcSEcCtD
Cysteamine—SST—Signaling Pathways—H2AFZ—testicular cancer	0.000311	0.00704	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—STK11—testicular cancer	0.000309	0.007	CbGpPWpGaD
Cysteamine—Somnolence—Etoposide—testicular cancer	0.000308	0.00198	CcSEcCtD
Cysteamine—Nausea—Bleomycin—testicular cancer	0.000304	0.00196	CcSEcCtD
Cysteamine—Vomiting—Dactinomycin—testicular cancer	0.000304	0.00196	CcSEcCtD
Cysteamine—Rash—Dactinomycin—testicular cancer	0.000301	0.00194	CcSEcCtD
Cysteamine—Decreased appetite—Etoposide—testicular cancer	0.000301	0.00194	CcSEcCtD
Cysteamine—Diarrhoea—Ifosfamide—testicular cancer	0.0003	0.00193	CcSEcCtD
Cysteamine—Renal failure—Epirubicin—testicular cancer	0.000299	0.00193	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Etoposide—testicular cancer	0.000299	0.00193	CcSEcCtD
Cysteamine—Body temperature increased—Cisplatin—testicular cancer	0.000299	0.00193	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—H2AFZ—testicular cancer	0.000298	0.00675	CbGpPWpGaD
Cysteamine—Fatigue—Etoposide—testicular cancer	0.000298	0.00192	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—STK11—testicular cancer	0.000297	0.00671	CbGpPWpGaD
Cysteamine—Constipation—Etoposide—testicular cancer	0.000296	0.00191	CcSEcCtD
Cysteamine—Dizziness—Ifosfamide—testicular cancer	0.00029	0.00187	CcSEcCtD
Cysteamine—Urinary tract disorder—Methotrexate—testicular cancer	0.000288	0.00186	CcSEcCtD
Cysteamine—SST—Signaling Pathways—KITLG—testicular cancer	0.000286	0.00648	CbGpPWpGaD
Cysteamine—Urethral disorder—Methotrexate—testicular cancer	0.000286	0.00184	CcSEcCtD
Cysteamine—Feeling abnormal—Etoposide—testicular cancer	0.000285	0.00184	CcSEcCtD
Cysteamine—Nausea—Dactinomycin—testicular cancer	0.000284	0.00183	CcSEcCtD
Cysteamine—Gastrointestinal pain—Etoposide—testicular cancer	0.000283	0.00183	CcSEcCtD
Cysteamine—Vomiting—Ifosfamide—testicular cancer	0.000279	0.0018	CcSEcCtD
Cysteamine—Hypersensitivity—Cisplatin—testicular cancer	0.000278	0.0018	CcSEcCtD
Cysteamine—Renal failure—Doxorubicin—testicular cancer	0.000277	0.00178	CcSEcCtD
Cysteamine—Rash—Ifosfamide—testicular cancer	0.000276	0.00178	CcSEcCtD
Cysteamine—Dermatitis—Ifosfamide—testicular cancer	0.000276	0.00178	CcSEcCtD
Cysteamine—Urticaria—Etoposide—testicular cancer	0.000275	0.00177	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—KITLG—testicular cancer	0.000274	0.00621	CbGpPWpGaD
Cysteamine—Abdominal pain—Etoposide—testicular cancer	0.000274	0.00176	CcSEcCtD
Cysteamine—Body temperature increased—Etoposide—testicular cancer	0.000274	0.00176	CcSEcCtD
Cysteamine—Asthenia—Cisplatin—testicular cancer	0.000271	0.00175	CcSEcCtD
Cysteamine—Urinary tract disorder—Epirubicin—testicular cancer	0.00027	0.00174	CcSEcCtD
Cysteamine—Connective tissue disorder—Epirubicin—testicular cancer	0.000268	0.00173	CcSEcCtD
Cysteamine—Urethral disorder—Epirubicin—testicular cancer	0.000268	0.00173	CcSEcCtD
Cysteamine—Immune system disorder—Methotrexate—testicular cancer	0.000264	0.0017	CcSEcCtD
Cysteamine—Nausea—Ifosfamide—testicular cancer	0.00026	0.00168	CcSEcCtD
Cysteamine—Diarrhoea—Cisplatin—testicular cancer	0.000258	0.00167	CcSEcCtD
Cysteamine—Mental disorder—Methotrexate—testicular cancer	0.000256	0.00165	CcSEcCtD
Cysteamine—Hypersensitivity—Etoposide—testicular cancer	0.000255	0.00164	CcSEcCtD
Cysteamine—Malnutrition—Methotrexate—testicular cancer	0.000254	0.00164	CcSEcCtD
Cysteamine—Erythema—Methotrexate—testicular cancer	0.000254	0.00164	CcSEcCtD
Cysteamine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000249	0.00161	CcSEcCtD
Cysteamine—Asthenia—Etoposide—testicular cancer	0.000248	0.0016	CcSEcCtD
Cysteamine—Connective tissue disorder—Doxorubicin—testicular cancer	0.000248	0.0016	CcSEcCtD
Cysteamine—Urethral disorder—Doxorubicin—testicular cancer	0.000248	0.0016	CcSEcCtD
Cysteamine—Immune system disorder—Epirubicin—testicular cancer	0.000247	0.00159	CcSEcCtD
Cysteamine—Vomiting—Cisplatin—testicular cancer	0.00024	0.00155	CcSEcCtD
Cysteamine—Mental disorder—Epirubicin—testicular cancer	0.000239	0.00154	CcSEcCtD
Cysteamine—Rash—Cisplatin—testicular cancer	0.000238	0.00154	CcSEcCtD
Cysteamine—Dermatitis—Cisplatin—testicular cancer	0.000238	0.00153	CcSEcCtD
Cysteamine—Malnutrition—Epirubicin—testicular cancer	0.000238	0.00153	CcSEcCtD
Cysteamine—Erythema—Epirubicin—testicular cancer	0.000238	0.00153	CcSEcCtD
Cysteamine—Diarrhoea—Etoposide—testicular cancer	0.000237	0.00153	CcSEcCtD
Cysteamine—Anaemia—Methotrexate—testicular cancer	0.000235	0.00151	CcSEcCtD
Cysteamine—Tension—Epirubicin—testicular cancer	0.000233	0.0015	CcSEcCtD
Cysteamine—Nervousness—Epirubicin—testicular cancer	0.000231	0.00149	CcSEcCtD
Cysteamine—Dizziness—Etoposide—testicular cancer	0.000229	0.00148	CcSEcCtD
Cysteamine—Immune system disorder—Doxorubicin—testicular cancer	0.000228	0.00147	CcSEcCtD
Cysteamine—Leukopenia—Methotrexate—testicular cancer	0.000227	0.00147	CcSEcCtD
Cysteamine—Nausea—Cisplatin—testicular cancer	0.000224	0.00145	CcSEcCtD
Cysteamine—Mental disorder—Doxorubicin—testicular cancer	0.000221	0.00143	CcSEcCtD
Cysteamine—Convulsion—Methotrexate—testicular cancer	0.00022	0.00142	CcSEcCtD
Cysteamine—Vomiting—Etoposide—testicular cancer	0.00022	0.00142	CcSEcCtD
Cysteamine—Malnutrition—Doxorubicin—testicular cancer	0.00022	0.00142	CcSEcCtD
Cysteamine—Erythema—Doxorubicin—testicular cancer	0.00022	0.00142	CcSEcCtD
Cysteamine—Anaemia—Epirubicin—testicular cancer	0.00022	0.00142	CcSEcCtD
Cysteamine—Agitation—Epirubicin—testicular cancer	0.000218	0.00141	CcSEcCtD
Cysteamine—Rash—Etoposide—testicular cancer	0.000218	0.00141	CcSEcCtD
Cysteamine—Dermatitis—Etoposide—testicular cancer	0.000218	0.00141	CcSEcCtD
Cysteamine—Headache—Etoposide—testicular cancer	0.000217	0.0014	CcSEcCtD
Cysteamine—Tension—Doxorubicin—testicular cancer	0.000216	0.00139	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000215	0.00139	CcSEcCtD
Cysteamine—Discomfort—Methotrexate—testicular cancer	0.000214	0.00138	CcSEcCtD
Cysteamine—Nervousness—Doxorubicin—testicular cancer	0.000214	0.00138	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGFR3—testicular cancer	0.000213	0.00481	CbGpPWpGaD
Cysteamine—Leukopenia—Epirubicin—testicular cancer	0.000213	0.00137	CcSEcCtD
Cysteamine—Confusional state—Methotrexate—testicular cancer	0.000209	0.00135	CcSEcCtD
Cysteamine—Anaphylactic shock—Methotrexate—testicular cancer	0.000207	0.00134	CcSEcCtD
Cysteamine—Convulsion—Epirubicin—testicular cancer	0.000206	0.00133	CcSEcCtD
Cysteamine—Nausea—Etoposide—testicular cancer	0.000206	0.00133	CcSEcCtD
Cysteamine—Hypertension—Epirubicin—testicular cancer	0.000205	0.00132	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—FGFR3—testicular cancer	0.000204	0.00461	CbGpPWpGaD
Cysteamine—Nervous system disorder—Methotrexate—testicular cancer	0.000203	0.00131	CcSEcCtD
Cysteamine—Anaemia—Doxorubicin—testicular cancer	0.000203	0.00131	CcSEcCtD
Cysteamine—Agitation—Doxorubicin—testicular cancer	0.000202	0.0013	CcSEcCtD
Cysteamine—Skin disorder—Methotrexate—testicular cancer	0.000201	0.0013	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000201	0.0013	CcSEcCtD
Cysteamine—Discomfort—Epirubicin—testicular cancer	0.0002	0.00129	CcSEcCtD
Cysteamine—Anorexia—Methotrexate—testicular cancer	0.000198	0.00127	CcSEcCtD
Cysteamine—Leukopenia—Doxorubicin—testicular cancer	0.000197	0.00127	CcSEcCtD
Cysteamine—Confusional state—Epirubicin—testicular cancer	0.000196	0.00126	CcSEcCtD
Cysteamine—SST—Signaling Pathways—KIT—testicular cancer	0.000195	0.00442	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Epirubicin—testicular cancer	0.000194	0.00125	CcSEcCtD
Cysteamine—Convulsion—Doxorubicin—testicular cancer	0.000191	0.00123	CcSEcCtD
Cysteamine—Nervous system disorder—Epirubicin—testicular cancer	0.00019	0.00123	CcSEcCtD
Cysteamine—Hypertension—Doxorubicin—testicular cancer	0.00019	0.00122	CcSEcCtD
Cysteamine—Skin disorder—Epirubicin—testicular cancer	0.000188	0.00122	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—KIT—testicular cancer	0.000187	0.00424	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000186	0.0012	CcSEcCtD
Cysteamine—Discomfort—Doxorubicin—testicular cancer	0.000185	0.00119	CcSEcCtD
Cysteamine—Anorexia—Epirubicin—testicular cancer	0.000185	0.00119	CcSEcCtD
Cysteamine—Somnolence—Methotrexate—testicular cancer	0.000184	0.00119	CcSEcCtD
Cysteamine—Dyspepsia—Methotrexate—testicular cancer	0.000182	0.00118	CcSEcCtD
Cysteamine—Confusional state—Doxorubicin—testicular cancer	0.000181	0.00117	CcSEcCtD
Cysteamine—Decreased appetite—Methotrexate—testicular cancer	0.00018	0.00116	CcSEcCtD
Cysteamine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000179	0.00116	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000179	0.00115	CcSEcCtD
Cysteamine—Fatigue—Methotrexate—testicular cancer	0.000179	0.00115	CcSEcCtD
Cysteamine—Nervous system disorder—Doxorubicin—testicular cancer	0.000176	0.00114	CcSEcCtD
Cysteamine—Skin disorder—Doxorubicin—testicular cancer	0.000174	0.00112	CcSEcCtD
Cysteamine—Somnolence—Epirubicin—testicular cancer	0.000172	0.00111	CcSEcCtD
Cysteamine—Anorexia—Doxorubicin—testicular cancer	0.000171	0.0011	CcSEcCtD
Cysteamine—Feeling abnormal—Methotrexate—testicular cancer	0.000171	0.0011	CcSEcCtD
Cysteamine—Dyspepsia—Epirubicin—testicular cancer	0.000171	0.0011	CcSEcCtD
Cysteamine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000169	0.00109	CcSEcCtD
Cysteamine—Decreased appetite—Epirubicin—testicular cancer	0.000169	0.00109	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000167	0.00108	CcSEcCtD
Cysteamine—Fatigue—Epirubicin—testicular cancer	0.000167	0.00108	CcSEcCtD
Cysteamine—Constipation—Epirubicin—testicular cancer	0.000166	0.00107	CcSEcCtD
Cysteamine—Urticaria—Methotrexate—testicular cancer	0.000165	0.00106	CcSEcCtD
Cysteamine—Body temperature increased—Methotrexate—testicular cancer	0.000164	0.00106	CcSEcCtD
Cysteamine—Abdominal pain—Methotrexate—testicular cancer	0.000164	0.00106	CcSEcCtD
Cysteamine—Feeling abnormal—Epirubicin—testicular cancer	0.00016	0.00103	CcSEcCtD
Cysteamine—Somnolence—Doxorubicin—testicular cancer	0.00016	0.00103	CcSEcCtD
Cysteamine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000159	0.00102	CcSEcCtD
Cysteamine—Dyspepsia—Doxorubicin—testicular cancer	0.000158	0.00102	CcSEcCtD
Cysteamine—Decreased appetite—Doxorubicin—testicular cancer	0.000156	0.00101	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000155	0.001	CcSEcCtD
Cysteamine—Fatigue—Doxorubicin—testicular cancer	0.000155	0.000998	CcSEcCtD
Cysteamine—Urticaria—Epirubicin—testicular cancer	0.000154	0.000994	CcSEcCtD
Cysteamine—Constipation—Doxorubicin—testicular cancer	0.000153	0.00099	CcSEcCtD
Cysteamine—Abdominal pain—Epirubicin—testicular cancer	0.000153	0.000989	CcSEcCtD
Cysteamine—Body temperature increased—Epirubicin—testicular cancer	0.000153	0.000989	CcSEcCtD
Cysteamine—Hypersensitivity—Methotrexate—testicular cancer	0.000153	0.000985	CcSEcCtD
Cysteamine—Asthenia—Methotrexate—testicular cancer	0.000149	0.000959	CcSEcCtD
Cysteamine—Feeling abnormal—Doxorubicin—testicular cancer	0.000148	0.000954	CcSEcCtD
Cysteamine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000147	0.000947	CcSEcCtD
Cysteamine—Hypersensitivity—Epirubicin—testicular cancer	0.000143	0.000922	CcSEcCtD
Cysteamine—Urticaria—Doxorubicin—testicular cancer	0.000143	0.00092	CcSEcCtD
Cysteamine—Abdominal pain—Doxorubicin—testicular cancer	0.000142	0.000915	CcSEcCtD
Cysteamine—Body temperature increased—Doxorubicin—testicular cancer	0.000142	0.000915	CcSEcCtD
Cysteamine—Diarrhoea—Methotrexate—testicular cancer	0.000142	0.000915	CcSEcCtD
Cysteamine—Asthenia—Epirubicin—testicular cancer	0.000139	0.000898	CcSEcCtD
Cysteamine—Dizziness—Methotrexate—testicular cancer	0.000137	0.000884	CcSEcCtD
Cysteamine—Diarrhoea—Epirubicin—testicular cancer	0.000133	0.000856	CcSEcCtD
Cysteamine—Hypersensitivity—Doxorubicin—testicular cancer	0.000132	0.000853	CcSEcCtD
Cysteamine—Vomiting—Methotrexate—testicular cancer	0.000132	0.00085	CcSEcCtD
Cysteamine—Rash—Methotrexate—testicular cancer	0.000131	0.000843	CcSEcCtD
Cysteamine—Dermatitis—Methotrexate—testicular cancer	0.000131	0.000842	CcSEcCtD
Cysteamine—Headache—Methotrexate—testicular cancer	0.00013	0.000838	CcSEcCtD
Cysteamine—Asthenia—Doxorubicin—testicular cancer	0.000129	0.000831	CcSEcCtD
Cysteamine—Dizziness—Epirubicin—testicular cancer	0.000128	0.000827	CcSEcCtD
Cysteamine—Vomiting—Epirubicin—testicular cancer	0.000123	0.000796	CcSEcCtD
Cysteamine—Nausea—Methotrexate—testicular cancer	0.000123	0.000794	CcSEcCtD
Cysteamine—Diarrhoea—Doxorubicin—testicular cancer	0.000123	0.000792	CcSEcCtD
Cysteamine—Rash—Epirubicin—testicular cancer	0.000122	0.000789	CcSEcCtD
Cysteamine—Dermatitis—Epirubicin—testicular cancer	0.000122	0.000788	CcSEcCtD
Cysteamine—Headache—Epirubicin—testicular cancer	0.000122	0.000784	CcSEcCtD
Cysteamine—Dizziness—Doxorubicin—testicular cancer	0.000119	0.000766	CcSEcCtD
Cysteamine—Nausea—Epirubicin—testicular cancer	0.000115	0.000743	CcSEcCtD
Cysteamine—Vomiting—Doxorubicin—testicular cancer	0.000114	0.000736	CcSEcCtD
Cysteamine—Rash—Doxorubicin—testicular cancer	0.000113	0.00073	CcSEcCtD
Cysteamine—Dermatitis—Doxorubicin—testicular cancer	0.000113	0.000729	CcSEcCtD
Cysteamine—Headache—Doxorubicin—testicular cancer	0.000112	0.000725	CcSEcCtD
Cysteamine—Nausea—Doxorubicin—testicular cancer	0.000107	0.000688	CcSEcCtD
